Panel of antibodies used for diagnosis
Antibody . | Source . |
|---|---|
| Anti-L26 | DAKO |
| Anti-CD79a | Bio-Optica |
| Anti-Ki67 | Bio-Optica |
| Anti-IgM | DAKO |
| Anti-IgA | DAKO |
| Anti-IgG | DAKO |
| Anti-IgD | DAKO |
| Anti-κ | DAKO |
| Anti-λ | DAKO |
| Anti-C-MYC | Bio-Optica |
| Anti-p53 | DAKO |
| Anti-Bcl-2 | Bio-Optica |
| Anti-Bcl-6 | DAKO |
| Anti-CD10 | Neomarkers |
| Anti-LMP-1 | DAKO |
Antibody . | Source . |
|---|---|
| Anti-L26 | DAKO |
| Anti-CD79a | Bio-Optica |
| Anti-Ki67 | Bio-Optica |
| Anti-IgM | DAKO |
| Anti-IgA | DAKO |
| Anti-IgG | DAKO |
| Anti-IgD | DAKO |
| Anti-κ | DAKO |
| Anti-λ | DAKO |
| Anti-C-MYC | Bio-Optica |
| Anti-p53 | DAKO |
| Anti-Bcl-2 | Bio-Optica |
| Anti-Bcl-6 | DAKO |
| Anti-CD10 | Neomarkers |
| Anti-LMP-1 | DAKO |
Each source is in Milan, Italy, except Neomarkers, which is located in Fremont, California.
LMP indicates latent marker protein.